The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals with alcohol addiction Vancouver, ...

But while platform trials have the potential to be more effective and less expensive than traditional trials, challenges ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and ...

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 4 of its ...

An invaluable resource is being starved to death with no scientific or ethical justification ...

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

Jaswanth Kumar Vuggumudi's work underscores the significance of these advancements, emphasizing their role in shaping the ...

Employees at Fox Chase Cancer Center’s Office of Clinical Research in Philadelphia on March 26 voted to ratify their first ...

Lipocine has announced the commencement of a Phase III clinical trial of LPCN 1154, being developed for postpartum depression ...

First patient in Cohort four has been treated with TTX-MC138 Ten patients have been treated with TTX-MC138 at escalating dose levels Additional patients being evaluated ...

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face ...